- Report
- September 2019
- 13 Pages
Global
€9101EUR$10,000USD£7,802GBP
- Report
- October 2024
- 78 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 114 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- August 2023
- 72 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- December 2024
- 348 Pages
Global
From €2416EUR$2,655USD£2,071GBP
- Report
- December 2024
- 90 Pages
United States
From €1981EUR$2,177USD£1,699GBP
- Report
- November 2024
- 110 Pages
North America
From €2223EUR$2,443USD£1,906GBP
- Report
- November 2024
- 90 Pages
Australia
From €1692EUR$1,859USD£1,450GBP
- Report
- November 2024
- 150 Pages
United Kingdom
From €1812EUR$1,991USD£1,553GBP
- Report
- November 2024
- 130 Pages
Asia Pacific
From €1692EUR$1,859USD£1,450GBP
- Report
- November 2024
- 150 Pages
Europe
From €2054EUR$2,257USD£1,761GBP
- Report
- April 2024
- 350 Pages
Global
From €3495EUR$3,840USD£2,996GBP
- Report
- November 2022
- 310 Pages
Global
From €3495EUR$3,840USD£2,996GBP
- Report
- October 2022
- 258 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- October 2012
- 1570 Pages

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more